Ampelopsin, a small molecule inhibitor of HIV-1 infection targeting HIV entry

Biomedical and Environmental Sciences

Volumn 17, Issue 2, 2004, Pages 153-164

  Liu, De Yu ^a,c   Ye, Jian Tao ^a   Yang, Wen Hui ^a   Yan, Jin ^b   Zeng, Chang Hong ^b   Zeng, Sa ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Ampelopsin; Cellular immunity; Chemokine receptors; HIV 1

Indexed keywords

AMPELOPSIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHEMOKINE; FLAVONOID; RANTES; RECEPTOR CXCR4; RECEPTOR SUBTYPE; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROTECTION; CELLULAR IMMUNITY; CHEMOTAXIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; EXPERIMENTAL MODEL; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; VIRUS INHIBITION;

AMPELOPSIS; ANIMALS; ANTI-HIV AGENTS; CELL LINE; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; DOWN-REGULATION; DRUGS, CHINESE HERBAL; FLAVONOIDS; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; PLANT ROOTS; RANTES; RECEPTORS, CXCR4; SPLEEN; T-LYMPHOCYTES;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 4243053700     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Maddon, P. J., Dalgleish, A. G., McDougal, J. S., Clapham, P. R., Weiss, R. A., and Axel, R. (1986). The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47, 333-348.
2. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di-Marzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R., and Landau, N. R., (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
3. Feng, Y., Broder, C. C., Kennedy, P. E., and Berger, E. A. (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
4. Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., and Lusso, P. (1995). Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811-1815.
5. Amara, A., Gall, S. L., Schwartz, O., Salamero, J., Montes, M., Loetscher, P., Baggiolini, M., Virelizier, J. L., and Arenzana-Seisdedos, F. (1997). HIV coreceptor downregulation as antiviral principle: SDF-1 α -dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186, 139-146.
6. Wang, M. X., Liu, W. Z., Huang, A. D., Luo, L. Q., and Zhou, A. Q. (1989). Isolation and identification on the consistuents of flavonoids in Radix Ampelopsis Cantoniensis. J. Chine. Med. Mat. 12 (7), 28-30. (In Chinese)
7. Liu, D. Y., Luo, M., Xie, B. F., Feng, G. K., Zhu, X. F., and Liu, Z. C. (2001). Antitumor effects of ampelopsin. Chin. J. Cancer 20, 1372-1375. (In Chinese)
8. Liu, D. Y., Qiu, M. Q., and Liang, T. Y. (1999). Extraction and isolation of Ampelopsin from Ampelopsis Cantoniensis Planch and its inhibitory effect on B16 melanoma. Acad. J. SUMS. 20 (2), 127-129. (In Chinese)
9. Mack, M., Luckow, B., Nelson, P. J., Cihak, J., Simmons, G., Clapham, P. R., Signoret, N., Marsh, M., Stangassinger, M., Borlat, F., Wells, T. N., Schlondorff, D., and Proudfoot, A. E. (1998). Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J. Exp. Med. 187, 1215-1224.
10. Dimitrov, D. H., Melnick, J. L., and Hollinger, F. B. (1990). Microculture assay for isolation of Human Immunodeficiency Virus type 1 and for titration of infected peripheral blood mononuclear cells. J. Clin. Micro. 28, 734-737.
11. Scarlatti, G., Tresoldi, E., Bjorndal, A., Fredriksson, R., Colognesi, C., Deng, H. K., Malnati, M. S., Plebani, A., Siccardi, A. G., Littman, D. R., Fenyo, E. M., and Lusso, P. (1997). In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3, 1259-1265.
12. Cotter, R. L., Zheng, J. L., Che, M., Niemann, D., Liu, Y., He, J., Thomas, E., and Gendelman, H. E. (2001). Regulation of human immunodeficiency virus type 1 infection, β-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry. J. Virol. 75, 4308-4320.
13. Moore, J. P., McKeating, J. A., Huang, Y. X., Ashkenazi, A., and Ho, D. D. (1992). Virions of primary Human Immunodeficiency Virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J. Virol. 66, 235-243.
14. Ditzel, H. J., Rosenkilde, M. M., Garred, P., Wang, M., Koefoed, K., Pedersen, C., Burton, D. R., and Schwartz, T. W. (1998). The CCR5 receptor acts as an alloantigen in CCR5 Δ 32 homozygous individuals: identification of chemokine and HIV-1 blocking human antibodies. Proc. Natl. Acad. Sci. USA. 95, 5241-5245.
15. Trkola, A., Ketas, T. J., Nagashima, K. A., Zhao, L., Cilliers, T., Morris, L., Morre, J. P., Maddon, P. J., and Olson, W. C. (2001). Potent, broad-spectrum inhibition of Human Immunodeficiency Virus type 1 by the CCR5 monoclonal antibody PRO 140. J. Virol. 75, 579-588.
16. Zheng, Y. T., Ben, K. L., and Jin, S. W. (1999) Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronicaly infected T-lymphocytes. Acta Pharmacol. Sin. 20, 239-243.
17. Proost, P., DeMeester, I., Schols, D., Struyf, S., Lambeir, A. M., Wuyts, A., Opdenakker, G., DeClercq, E., Scharpe, S., and Van Damme, J. (1998). Amino-terminal truncation of chemokines by CD26/dipeptidylpeptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J. Biol. Chem. 273, 7222-7227.
18. Torre, V. S., Marozsan, A. J., Albright, J. L., Collins, K. R., Hartley, O., Offord, R. E., Quinones-Mateu, M. E., and Arts, E. J. (2000). Variable sensitivity of CCR5-Tropic Human Immunodeficiency Virus type 1 isolates to inhibition by RANTES analogs. J. Virol. 74, 4868-4876.
19. Zhu, X. H., Hou, W. J., Shen, L., and Tang, C. J. (1998). A comparison between two immunoinhibition animal models-Cy model and-Hy model. Chine. J. Exp. & Clin. Immunol. 10(5), 29-31. (In Chinese)
20. Xue, B. (1995). Immune Toxicological Experimental Method, 1st ed. Peking Medical Unvi Press, Peking. (In Chinese)
21. Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., and Springer, T. A. (1996). A high efficacious lymphocyte chemoattractant, Stromal Cell-derived Factor 1(SDF-1). J. Exp. Med. 184, 1101-1109.
22. Hesselgesser, J., Liang, M., Hoxie, J., Greenberg, M., Brass, L. F., Orsini, M. J., Taub, D., and Horuk, R. (1998). Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. J. Immunol. 160, 877-883.
23. Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J., and De Clercq, E. (1988). Rapid and automated tetraolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20, 309-321.
24. Viscidi, R., Farzadegan, H., Leister, F., Francisco, M. L., and Yolken, R. (1988). Enzyme immunoassay for detection of human immunodeficiency virus antigens in cell cultures. J. Clin. Microbiol. 26, 453-458.
25. Cao, J., Park, I. W., Cooper, A., and Sodroski, J. (1996). Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. J. Virol. 70, 1340-1354.
26. Sande, M. A., Carpenter, C. C., Cobbs, C. G., Holmes, K. K., and Sanford, J. P. (1993). Antiretroviral therapy for adult HIV infected patients. J. A. M. A. 270, 2583-2589.
27. Popik, W. and Pitha, P. M. (2000). Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry. Virology 276, 1-6.
28. Atchison, R. E., Gosling, J., Monteclaro, P. S., Franci, C., Digilio, L., Charo, I. F., and Goldsmith, M. A. (1996). Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 274, 1924-1926.
29. Campbell, J. J., Qin, S., Bacon, K. B., Mackay, C. R., and Butcher, E. C. (1996). Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells. J. Cell Biol. 134, 255-266.
30. Ma, Q., Jones, D., Borghesani, P. R., Segal, R. A., Negasawa, T., Kishimoto, T., Bronson, R. T., and Springer, T. A. (1998). Impaired B-lymphopoiesis, myelopoiesis and derailed cerebellar neuron migration in CXCR4 and SDF-1 deficient mice. Proc. Natl. Acad. Sci. USA. 95, 9448-9453.
31. Proudfoot, A. E. I., Power, C. A., and Wells, T. N. (2000). The strategy of blocking the chemokine system to combat disease. Immunol. Rev. 177, 246-256.
32. Carre, N., Boufassa, F., Hubert, J. B., Chavance, M., Rouzioux, C., Goujard, C., Laurian, Y., and Meyer, L. (1998). Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. Int. J. Epidemiol. 27, 897-903.
33. Levy, J. A. (1993). The transmission of HIV and factors influencing progression to AIDS. Am. J. Med. 95, 86-100.
34. + T cells and this effect overrides its ability to stimulate virus expression. Proc. Natl. Acad. Sci. USA. 92, 10985-10989.
35. Clerici, M., Balotta, C. Salvaggio, A., Riva, C., Trabattoni, D., Papagno, L., Berlusconi, A., Rusconi, S., Villa, M. L., Moroni, M., and Galli, M. (1996). Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 88, 574-579.